↓ Skip to main content

Sigma Receptors: Their Role in Disease and as Therapeutic Targets

Overview of attention for book
Sigma Receptors: Their Role in Disease and as Therapeutic Targets
Springer International Publishing

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction to Sigma Receptors: Their Role in Disease and as Therapeutic Targets
  3. Altmetric Badge
    Chapter 2 Structural Perspectives on Sigma-1 Receptor Function
  4. Altmetric Badge
    Chapter 3 A Review of the Human Sigma-1 Receptor Structure
  5. Altmetric Badge
    Chapter 4 Fluorinated PET Tracers for Molecular Imaging of σ1 Receptors in the Central Nervous System
  6. Altmetric Badge
    Chapter 5 The Evolution of the Sigma-2 (σ2) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target
  7. Altmetric Badge
    Chapter 6 Sigma 1 Receptor and Ion Channel Dynamics in Cancer
  8. Altmetric Badge
    Chapter 7 Sigma-1 Receptors Fine-Tune the Neuronal Networks
  9. Altmetric Badge
    Chapter 8 Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain
  10. Altmetric Badge
    Chapter 9 Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics
  11. Altmetric Badge
    Chapter 10 Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection
  12. Altmetric Badge
    Chapter 11 Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders
  13. Altmetric Badge
    Chapter 12 Role of Sigma-1 Receptor in Cocaine Abuse and Neurodegenerative Disease
  14. Altmetric Badge
    Chapter 13 Sigma Receptors and Substance Use Disorders
  15. Altmetric Badge
    Chapter 14 Stimulation of the Sigma-1 Receptor and the Effects on Neurogenesis and Depressive Behaviors in Mice
  16. Altmetric Badge
    Chapter 15 Role of σ1 Receptors in Learning and Memory and Alzheimer’s Disease-Type Dementia
  17. Altmetric Badge
    Chapter 16 Sigma-1 Receptor in Motoneuron Disease
  18. Altmetric Badge
    Chapter 17 The Sigma-1 Receptor–A Therapeutic Target for the Treatment of ALS?
  19. Altmetric Badge
    Chapter 18 The Role of Sigma1R in Mammalian Retina
  20. Altmetric Badge
    Chapter 19 Peeking into Sigma-1 Receptor Functions Through the Retina
  21. Altmetric Badge
    Chapter 20 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Attention for Chapter 15: Role of σ1 Receptors in Learning and Memory and Alzheimer’s Disease-Type Dementia
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
wikipedia
1 Wikipedia page

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Role of σ1 Receptors in Learning and Memory and Alzheimer’s Disease-Type Dementia
Chapter number 15
Book title
Sigma Receptors: Their Role in Disease and as Therapeutic Targets
Published in
Advances in experimental medicine and biology, March 2017
DOI 10.1007/978-3-319-50174-1_15
Pubmed ID
Book ISBNs
978-3-31-950172-7, 978-3-31-950174-1
Authors

Tangui Maurice, Nino Goguadze, Maurice, Tangui, Goguadze, Nino

Editors

Sylvia B. Smith, Tsung-Ping Su

Abstract

The present chapter will review the role of σ1 receptor in learning and memory and neuroprotection , against Alzheimer's type dementia. σ1 Receptor agonists have been tested in a variety of pharmacological and pathological models of learning impairments in rodents these last past 20 years. Their anti-amnesic effects have been explained by the wide-range modulatory role of σ1 receptors on Ca(2+) mobilizations, neurotransmitter responses, and particularly glutamate and acetylcholine systems, and neurotrophic factors. Recent observations from genetic and pharmacological studies have shown that σ1 receptor can also be targeted in neurodegenerative diseases, and particularly Alzheimer's disease . Several compounds, acting partly through the σ1 receptor, have showed effective neuroprotection in transgenic mouse models of Alzheimer's disease . We will review the data and discuss the possible mechanisms of action, particularly focusing on oxidative stress and mitochondrial integrity, trophic factors and a novel hypothesis suggesting a functional interaction between the σ1 receptor and α7 nicotinic acetylcholine receptor. Finally, we will discuss the pharmacological peculiarities of non-selective σ1 receptor ligands, now developed as neuroprotectants in Alzheimer's disease , and positive modulators, recently described and that showed efficacy against learning and memory deficits.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 23%
Researcher 4 15%
Student > Bachelor 4 15%
Student > Master 3 12%
Other 1 4%
Other 1 4%
Unknown 7 27%
Readers by discipline Count As %
Medicine and Dentistry 4 15%
Agricultural and Biological Sciences 3 12%
Neuroscience 3 12%
Biochemistry, Genetics and Molecular Biology 2 8%
Chemistry 2 8%
Other 3 12%
Unknown 9 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2023.
All research outputs
#3,097,895
of 23,733,540 outputs
Outputs from Advances in experimental medicine and biology
#484
of 5,040 outputs
Outputs of similar age
#62,236
of 336,203 outputs
Outputs of similar age from Advances in experimental medicine and biology
#3
of 76 outputs
Altmetric has tracked 23,733,540 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,040 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 336,203 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.